Relationship Between Level of Hepatitis B Virus DNA and Liver Disease: A Population-based Study of Hepatitis B e Antigen-Negative Persons With Hepatitis B

Clinical Gastroenterology and Hepatology

Volumn 12, Issue 4, 2014, Pages

  McMahon, Brian J ^a,b   Bulkow, Lisa ^b   Simons, Brenna ^a   Zhang, Yuhong ^d   Negus, Susan ^a   Homan, Chriss ^a   Spradling, Philip ^c   Teshale, Eyasu ^c   Lau, Daryl ^d   Snowball, Mary ^a   Livingston, Stephen E ^a  

^a ALASKA NATIVE TRIBAL HEALTH CONSORTIUM   (United States)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

HBsAg; HBV genotype; Liver biopsy

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIVIRUS AGENT; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ADULT; ANTIVIRAL THERAPY; ARTICLE; COHORT ANALYSIS; DEMOGRAPHY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; LIVER BIOPSY; LIVER FIBROSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; UNITED STATES;

HBSAG; HBV GENOTYPE; LIVER BIOPSY;

ADULT; ALANINE TRANSAMINASE; ALASKA; BIOPSY; COHORT STUDIES; DNA, VIRAL; FEMALE; HEPATITIS B ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HISTOCYTOCHEMISTRY; HUMANS; LIVER CIRRHOSIS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; VIRAL LOAD;

EID: 84896075562     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2013.09.005     Document Type: Article

References (14)

1. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. JViral Hepat 2004, 11:97-107.
2. Livingston S.E., Simonetti J.P., Bulkow L.R., et al. Clearance of hepatitis B e antigen in patients with chronic hepatitis B and genotypes A, B, C, D, and F. Gastroenterology 2007, 133:1452-1457.
3. Simonetti J., Bulkow L., McMahon B.J., et al. Clearance of hepatitis B surface antigen and risk of hepatocellular carcinoma in a cohort chronically infected with hepatitis B virus. Hepatology 2010, 51:1531-1537.
4. Lok A.S.F., McMahon B.J. Chronic hepatitis B: update 2009. Hepatology 2009, 50:661-662.
5. Ishak K., Baptista A., Bianchi L., et al. Histological grading and staging of chronic hepatitis. JHepatol 1995, 22:696-699.
6. Hoofnagle J.H., Doo E., Liang T.J., et al. Management of hepatitis B: summary of a clinical research workshop. Hepatology 2007, 45:1056-1075.
7. Liaw Y.F. Natural history of chronic hepatitis B virus infection and long-term outcome under treatment. Liver Int 2009, 29(Suppl 1):100-107.
8. Papatheodoridis G.V., Manolakopoulos S., Liaw Y.F., et al. Follow-up and indications for liver biopsy in HBeAg-negative chronic hepatitis B virus infection with persistently normal ALT: a systematic review. JHepatol 2012, 57:196-202.
9. Ikeda K., Arase Y., Saitoh S., et al. Long-term outcome of HBV carriers with negative HBe antigen and normal aminotransferase. Am J Med 2006, 119:977-985.
10. Zacharakis G., Koskinas J., Kotsiou S., et al. The role of serial measurement of serum HBV DNA levels in patients with chronic HBeAg(-) hepatitis B infection: association with liver disease progression-a prospective cohort study. JHepatol 2008, 49:884-891.
11. Hu K.-Q., Schiff E.R., Kowdley K.V., et al. Histologic evidence of active liver injury in chronic hepatitis B patients with normal range or minimally elevated alanine aminotransferase levels. JClin Gastroenterol 2010, 44:510-516.
12. Nguyen M.H., Garcia R.T., Trinh H.N., et al. Histological disease in Asian-Americans with chronic hepatitis B, high hepatitis B virus DNA, and normal alanine aminotransferase levels. Am J Gastroenterol 2009, 104:2206-2213.
13. Keeffe E.B., Dieterich D.T., Han S.H.B., et al. Atreatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update. Clin Gastroenterol Hepatol 2008, 6:1315-1341.
14. Brunetto M.R., Olivari F., Colombatto P., et al. Use of HBsAg serum levels help to distinguish active from inactive HBV genotype D carriers. Gastroenterology 2010, 139:483-490.